Imbria Pharmaceuticals

Imbria Pharmaceuticals

Phase 2
Cambridge, United StatesFounded 2018imbria.com

Unlocking the Power of Cardiac Energy Metabolism ABOUT Fueling the next generation of cardiovascular therapies We are translating our deep understanding of cardiac energy metabolism into novel cardiovascular disease treatments designed to transform care for patients with limited treatment options. By enhancing or restoring the cell’s ability to produce and use energy, we aim to […]

Founded
2018
Focus
Small Molecules

About

Unlocking the Power of Cardiac Energy Metabolism ABOUT Fueling the next generation of cardiovascular therapies We are translating our deep understanding of cardiac energy metabolism into novel cardiovascular disease treatments designed to transform care for patients with limited treatment options. By enhancing or restoring the cell’s ability to produce and use energy, we aim to […]

Funding History

2

Total raised: $170M

Series B$107MCormorant Asset ManagementJun 15, 2021
Series A$63MAtlas VentureJun 15, 2019

Company Info

TypePrivate
Founded2018
LocationCambridge, United States
StagePhase 2

Contact

SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile